Pembrolizumab KEYTRUDA®

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable TumorsNCT05280314IO BiotechPhase 2Recruiting2025-04-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.